• 14C custom radiolabelling, specialising in 14C GMP API, for metabolism, environmental fate and human ADME studies.
  • Structural elucidation and impurity profiling; synthesis and GLP characterisation of process impurity, degradation products and metabolites.
  • Unique peptidyl prolyl isomerase (PPIase) screening platform including binding and functional assays.
  • Providing integrated drug discovery services to pharma, biotechnology companies and academic institutions.

Drug Discovery

Providing integrated drug discovery services to pharma, biotechnology companies and academic institutions.

Read more

Medicinal Chemistry
Assay Development and Screening
Target Class and Disease Expertise

Radiolabelling

14C custom radiolabelling for metabolism, environmental fate and specialising in 14C GMP API for human ADME studies.

Read more

14C Custom Synthesis
14C GMP Radiolabelled API for Clinical Trials
GLP Analytics

Chemistry & Analytics

Structural elucidation and impurity profiling; synthesis and GLP characterisation of process impurity, degradation products and metabolites.

Read more

Custom Synthesis
Crop Science Expertise
GLP anaysis including GLP NMR

News

11 August 2016
Selcia and BioAscent Discovery (www.bioascent.com) have entered into an agreement to make Selcia’s...
10 August 2016
Selcia’s experienced team of medicinal chemists provided Novobiotic Pharmaceuticals with medicinal...

Upcoming Events

30 August 2016
Selcia’s Director of Discovery is speaking at Can Science Save the Day, The Museum of Science and Industry - Liverpool Road, Manchester.
6 September 2016 to 9 September 2016
Selcia is attending the Chemical Industries Regulations (CIR) AgChem Forum in Nice, France.

Selcia Tweets